Hyaluronate and Derivatives and Sinemet 250/25
Determining the interaction of Hyaluronate and Derivatives and Sinemet 250/25 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hyaluronan
Brand name: Hymovis, Monovisc, Orthovisc, Hydase
Synonyms: Hyaluronan
Generic Name: carbidopa / levodopa
Brand name: Parcopa, Rytary, Sinemet, Sinemet CR, Duopa
Synonyms: Carbidopa and levodopa, Carbidopa and Levodopa
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hyaluronate and Derivatives-Sinemet CR
- Hyaluronate and Derivatives-Sinemet CR 100/25
- Hyaluronate and Derivatives-Sinemet CR 200/50
- Hyaluronate and Derivatives-Sinequan
- Hyaluronate and Derivatives-Sinequan (Doxepin Capsules)
- Hyaluronate and Derivatives-Sinequan (Doxepin Oral Concentrate)
- Sinemet 250/25-Hyaluronate and Derivatives Injection (Knee)
- Sinemet 250/25-Hyaluronate sodium Injection
- Sinemet 250/25-Hyaluronidase
- Sinemet 250/25-Hyaluronidase and immune globulin
- Sinemet 250/25-Hyaluronidase and rituximab
- Sinemet 250/25-Hyaluronidase and trastuzumab